Please read and agree to the terms and conditions of this site.
@engadget.com 5 months ago
UK authorizes first gene therapy for treating sickle cell disease
@insitro 2 years ago
We're thrilled to announce our collaboration with @GenomicsEngland to bring our #MachineLearning-powered embedding search capabilities to their multimodal phenotypic and genetic database to create better medicines for patients in need. https://www.businesswire.com/news/home/20220309005401/en/insitro-and-Genomics-England-Announce-Partnership-to-Provide-Multimodal-Search-Capabilities-and-Empower-Data-Exploration-and-Derivation-of-Novel-Insights https://t.co/W7eGEQeEmI
@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com 3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com 3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com 3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com 3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com 3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com 4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@jminguezc 6 years ago
Deep #Genomics applies #MachineLearning to develop new genetic medicines. #BigData #DeepLearning #DataScience #AI… https://twitter.com/i/web/status/860032526815047680
@gp_pulipaka 6 years ago
Deep #Genomics applies #MachineLearning to develop new genetic medicines. #BigData #DeepLearning #DataScience #AI… https://twitter.com/i/web/status/859972374871015424